Gregory S Kelner

Title: Gregory S. Kelner: Innovator in G Protein-Coupled Receptor Modulation

Introduction

Gregory S. Kelner is a notable inventor based in San Diego, CA, recognized for his contributions to the field of biotechnology. His work primarily focuses on the modulation of G protein-coupled receptors (GPCRs), which play a crucial role in various cellular processes.

Latest Patents

Kelner holds a patent titled "Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders." This invention outlines methods for identifying candidate compounds that can modulate GPCRs, particularly those expressed in neuronal and muscle cells. The patent emphasizes the potential therapeutic applications of these modulators in treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease, as well as other conditions like stroke and ischemic heart disease. He has 1 patent to his name.

Career Highlights

Gregory S. Kelner is associated with Arena Pharmaceuticals, Inc., where he has made significant strides in research and development. His innovative approaches have contributed to the understanding of GPCRs and their implications in various medical conditions.

Collaborations

Kelner has collaborated with notable colleagues, including Sonia Villegas and David J. Unett, to advance research in the field of GPCR modulation. Their combined expertise has fostered a collaborative environment that encourages innovation and discovery.

Conclusion

Gregory S. Kelner's work in the modulation of G protein-coupled receptors represents a significant advancement in the treatment of cell death-related disorders. His contributions continue to impact the field of biotechnology and offer hope for therapeutic interventions in neurodegenerative diseases.